Folfox+Irinotecan+Chemort In Esophageal Cancer
Folfox+Irinotecan+Chemort In Esophageal Cancer
Recruiting · NCT04656041 · Registry updated 2025-11-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Folfox+Irinotecan+Chemort In Esophageal Cancer | gastroesophageal junction adenocarcinoma | Recruiting | Phase 2 | 2025-11-14 | NCT04656041 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ipsen | 59 |
| Massachusetts General Hospital | 758 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beth-Israel Deaconess Medical Center | Boston | United States | 5 |
| Massachusetts General Hospital | Boston | United States | 39 |
| Massachusetts General Hospital at Newton Wellesley Hospital | Newton | United States | 1 |